JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOLN
2976
DELISTED
The Southern Company
SOLN
| $2.86M | ﹤0.01% |
53,112
+51,712
| +3,694% | +$2.74M |
|
2977
TriMas Corp
TRS
$1.41B
| $2.86M | ﹤0.01% |
90,939
-5,243
| -5% | -$162K |
|
|
CGC
2978
PUT
Canopy Growth
CGC
$426M
| $2.86M | ﹤0.01% |
+13,540
| New | +$2.69M |
|
2979
Alamo Group
ALG
$2.01B
| $2.84M | ﹤0.01% |
22,625
+1,669
| +8% | +$195K |
|
|
PR
2980
Permian Resources
PR
$18B
| $2.84M | ﹤0.01% |
614,215
-2,413,467
| -80% | -$8.82M |
|
2981
Minerva Neurosciences
NERV
$187M
| $2.82M | ﹤0.01% |
49,628
+10,465
| +27% | +$461K |
|
|
AMWD
2982
DELISTED
American Woodmark
AMWD
| $2.82M | ﹤0.01% |
26,962
-36,012
| -57% | -$3.62M |
|
|
WLL
2983
DELISTED
Whiting Petroleum Corporation
WLL
| $2.81M | ﹤0.01% |
5,108
-812
| -14% | -$393K |
|
2984
CALL
Allstate
ALL
$64.7B
| $2.81M | ﹤0.01% |
25,000
| – | – |
|
2985
CALL
Toyota
TM
$223B
| $2.81M | ﹤0.01% |
20,000
-30,000
| -60% | -$4.19M |
|
|
2986
PUT
Toyota
TM
$223B
| $2.81M | ﹤0.01% |
20,000
-30,000
| -60% | -$4.19M |
|
2987
Paylocity
PCTY
$7.73B
| $2.81M | ﹤0.01% |
23,262
+4,743
| +26% | +$519K |
|
2988
TG Therapeutics
TGTX
$7.58B
| $2.81M | ﹤0.01% |
253,096
-19,992
| -7% | -$152K |
|
|
GTT
2989
PUT
DELISTED
GTT Communications, Inc.
GTT
| $2.81M | ﹤0.01% |
247,200
+212,300
| +608% | +$1.78M |
|
|
NUAN
2990
DELISTED
Nuance Communications, Inc.
NUAN
| $2.81M | ﹤0.01% |
157,309
-260,770
| -62% | -$4.32M |
|
2991
PUT
AMC Entertainment Holdings
AMC
$2.35B
| $2.8M | ﹤0.01% |
+38,730
| New | +$3.41M |
|
2992
EXL Service
EXLS
$5.36B
| $2.8M | ﹤0.01% |
201,540
-182,065
| -47% | -$2.49M |
|
2993
Honda
HMC
$40.6B
| $2.79M | ﹤0.01% |
98,692
-103,344
| -51% | -$2.88M |
|
|
ZGNX
2994
DELISTED
Zogenix, Inc.
ZGNX
| $2.79M | ﹤0.01% |
53,545
+13,458
| +34% | +$616K |
|
2995
Rhythm Pharmaceuticals
RYTM
$8.1B
| $2.78M | ﹤0.01% |
120,883
-5,661
| -4% | -$126K |
|
2996
Mitsubishi UFJ Financial
MUFG
$260B
| $2.77M | ﹤0.01% |
509,951
-23,242
| -4% | -$123K |
|
|
ONC
2997
BeOne Medicines Ltd
ONC
$40.6B
| $2.77M | ﹤0.01% |
16,697
+1,481
| +10% | +$246K |
|
2998
Sturm, Ruger & Co
RGR
$600M
| $2.76M | ﹤0.01% |
58,758
+48,648
| +481% | +$2.21M |
|
|
RYZ
2999
Ryerson Holding Corp
RYZ
$1.5B
| $2.76M | ﹤0.01% |
233,625
+9,325
| +4% | +$92.1K |
|
3000
Golub Capital BDC
GBDC
$3.48B
| $2.76M | ﹤0.01% |
152,751
-33,140
| -18% | -$585K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.